Recent news on Lipitor

Lipitor: Loser  -  25 May 2007
CNBC,...generic version of Zocor) Surpass It?" He goes on to write, "Simvastatin Still on Course to Catch Lipitor" (the bold type is his emphasis). "... (Merck's)

'The Statin Effects Study' Spills The Beans On Impact Of Most ...  -  25 May 2007
The Common Voice,It has been two years since I first blogged about an ongoing study looking at the negative impact of cholesterol-lowering statin drugs (Lipitor, Crestor,

Medco sees generic sales as ticket to fast growth  -  25 May 2007
NorthJersey.com,And in 2011, Lipitor, the biggest-selling drug in the world, will face the same fate. According to Snow, all of this translates into huge savings for

The grease wars  -  25 May 2007
Logan Daily News,Chef Matt Butoryak passed out baskets of crispy bacon as he quipped: "We have corporate underwriting from Lipitor." After all, eating out is often an

Lipitor co-founder will stay when Pfizer leaves  -  May 24, 2007
Michigan Business Review,The co-founder of Lipitor wants to start a new business in Ann Arbor, sending signals through the biotech community that key talent and investment will

Clinical Study Shows Natural Cholesterol Supplement Effective ...  -  May 24, 2007
PharmaLive.com (press release),MIAMI, May 23, 2007 /PRNewswire/ -- Many of the 152 million Americans with high cholesterol are prescribed statin drugs like Lipitor and Zocor but can't

Dr. Roger Newton, Co-Discoverer of Lipitor(R), Joins Resverlogix ...  -  May 14, 2007
Web Services Journal,...he co-discovered and was the product champion of what is now the most prescribed cholesterol reducing drug in the world, atorvastatin (Lipitor®).

Statin Helps Keep Second Strokes At Bay  -  May 22, 2007
The Ledger,Half the participants got a statin drug, which includes medications such as the brands Lipitor, Pravachol and Zocor. The other half did not receive the

Jarvik Resists Subpoena To Pump Him for Lipitor Info  -  Apr 30, 2007
Brandweek Magazine,NEW YORK -- Dr. Robert Jarvik, who stars in TV spots and print ads for Pfizer's Lipitor anti-cholesterol brand, is resisting a subpoena filed by several

Pfizer CEO shuffling lineup of top executives  -  May 22, 2007
Sun-Sentinel.com,Torcetrapib was supposed to replace Lipitor, the world's top-selling drug, accounting for more than 40 percent of Pfizer's sales.

Health Canada Approves Lipitor for the Reduction of the Risk of ...  -  Apr 25, 2007
CNW Telbec (Communiqués de presse),This new approval expands the use of Lipitor to patients at risk for cardiovascular events because of established heart disease such as a prior heart attack

Pfizer R&D President To Retire, CFO Resigns  -  May 20, 2007
Trading Markets,The drug, which was touted as Pfizer's replacement for its blockbuster cholesterol treatment - Lipitor, was killed in clinical studies last year on safety

UniPharm sues Pfizer Israel over Lipitor distribution  -  Apr 29, 2007
Globes,Under the September 2005 agreement, UniPharm would pay Pfizer a fixed commission on Lipitor sales in Israel and the Palestinian Authority.

Pfizer Research Head To Retire, CFO to Resign  -  May 21, 2007
St Petersburg Times, Russia,LaMattina, 57, was responsible for bringing in new products to replace the world’s best-selling medicine, Lipitor, which loses patent protection in 2010.

Pfizer to Replace Research, Finance Heads  -  May 20, 2007
Wall Street JournalThe drug was Pfizer's best hope for a blockbuster to replace Lipitor, the big-selling cholesterol treatment that loses patent protection as early as 2010.

Unilab set to contest patent of 4 drug items  -  May 20, 2007
Therapeutics Daily (subscription) (press release),...which prevents heart attacks. Lipitor and Unasyn are manufactured by Pfizer while Seretide is produced by GlaxoSmithKline. Plavix is retailed

Pfizer's R&D Head Will Retire This Year  -  May 21, 2007
Chemical & Engineering News...patent expiration looms for major products, including Lipitor, the leading statin therapy for cholesterol, which is scheduled to go off patent in 2011.

Pfizer CFO, Research Head to Leave  -  May 21, 2007
Forbes,Analysts are skeptical that the maker of Lipitor and Viagra can generate enough sales from current and pipeline products to counter billions to be lost in

EDITORIAL: Let market determine drug imports  -  May 18, 2007
Anderson Herald Bulletin,According to the Associated Press, 90 doses of Lipitor cost $321 in the United States and less than half of that if imported.

Ask the doctor  -  May 10, 2007
Portsmouth Herald News,Q: Does artificially lowering cholesterol with a statin drug like Lipitor have the same net effect in my blood and body as never having ingested fatty food

Zelnorm: Is it worth the Risk?  -  May 18, 2007
Lawyers and Settlements,He then put me on Lipitor and aspirin which supposedly will prevent me from having another stroke. "And I am having difficulty with short-term memory.

US carrying burden of drug research costs  -  Apr 25, 2007
Hilton Head Island Packet,About five years ago I bought Lipitor, a well known anti-cholesterol drug manufactured by Pfizer. The price was about $2.80 per tablet.

Two (or more) for one with prescription drugs  -  Apr 27, 2007
Los Angeles Times,If a patient is already taking Norvasc and Lipitor — and having two insurance copays — taking the drugs as a single Caduet pill will reduce the number of

Windhover Information's The RPM Report Earns Silver Award in 2007 ...  -  May 8, 2007
American Digital Networks (press release),The article, Pfizer's Lipitor Sees Big Boost from Medicare by Michael McCaughan, was the first in the industry to lay bare the strategy Pfizer used to coax

Windhover Information’s The RPM Report Earns Silver Award in 2007 ...  -  May 8, 2007
Business Wire (press release),The article, Pfizer’s Lipitor Sees Big Boost from Medicare by Michael McCaughan, was the first in the industry to lay bare the strategy Pfizer used to coax

MSU given former Pfizer lab  -  May 11, 2007
South Bend Tribune,...(AP) -- The now-shuttered lab that once gave birth to the popular cholesterol-lowering drug Lipitor soon could house scientists seeking new uses for

Health Canada Approves Lipitor for the Reduction of the Risk of ...  -  26 Apr 2007
CNW Telbec (Communiqués de presse),This new approval expands the use of Lipitor to patients at risk for cardiovascular events because of established heart disease such as a prior heart attack

BrandIntel Finds Lipitor Perceived Market Leader Among Statin Brands  -  Apr 23, 2007
WM Experts (press release),The report, "Statins Cholesterol Treatment Competitive Landscape," found Lipitor to be the perceived market leader in discussion, with Crestor being the

Ranbaxy fights Pfizer on generic drugs but wants strong home law ...  -  Apr 25, 2007
Down to Earth (subscription),It is filing for the right to manufacture generic versions of the world’s bestselling drug Lipitor and a combination drug Caduet, in the us.

Seventy-Eight Percent of Newly Diagnosed Dyslipidemia Patients Do ...  -  Apr 24, 2007
PR Newswire (press release),The report also finds that Pfizer's Lipitor remains the most popular first-line statin for the treatment of dyslipidemia.

Cure for Pfizer topic of investor debate  -  Apr 24, 2007
Therapeutics Daily (subscription) (press release),Its shares fell for a second day, down 2.5 percent to $26.30 in afternoon trading, after Pfizer warned on Friday that sales of Lipitor,

Lipitor receives FDA approval for new indications  -  Apr 15, 2007
ArabianBusiness.com,Pfizer has announced that the US Food and Drug Administration (FDA) has approved Lipitor (atorvastatin calcium) Tablets to reduce the risk of nonfatal heart

Pfizer Delivers Solid First-Quarter 2007 Results, Updates Full ...  -  Apr 20, 2007
PharmaLive.com (press release),...“We posted sales increases for Lipitor and Celebrex, and we were particularly pleased by the continuing strong performances of Chantix for smoking cessation

Pfizer cuts forecasts as generics threats become reality  -  Apr 23, 2007
Pharma Times (subscription),Leading the revenue rise once again was the cholesterol-lowerer Lipitor (atorvastatin), sales of which climbed 8% to $3.36 billion, while Celebrex

Ranbaxy's US launch of Lipitor drug only in 2010  -  Apr 3, 2007
Economic Times,NEW DELHI: With the US Supreme Court rejecting an appeal by Ranbaxy to launch a generic drug of Lipitor in the US before its patent expires in 2010,

Pfizer enlists doctors to defend Lipitor  -  Apr 2, 2007
USA TodayPfizer, faced with the potential loss of billions of dollars as patients with high cholesterol switch from Lipitor to generic Zocor, has been helping

High court rejects case on Lipitor's patent term  -  Apr 3, 2007
Baltimore Sun,WASHINGTON // Pfizer Inc. fought off a US Supreme Court appeal that aimed to open the company's Lipitor cholesterol pill, the most widely prescribed drug in

Ranbaxy`s launch of Lipitor drug likely in 2010  -  Apr 3, 2007
Myiris.com,Ranbaxy, will have to launch the generic drug of Lipitor in US, only after its patent expires in 2010, reports Economic Times. The US Supreme Court,

To Sell a Generic Version of Lipitor  -  Apr 2, 2007
Wall Street Journal (subscription),As the New York drug maker's patent on Lipitor nears expiration in 2010, the company had been working on a successor to the world's top-selling drug,

Lipitor provides unprecedented cardiovascular risk reductions in ...  -  Mar 27, 2007
CNW Telbec (Communiqués de presse),..."What's impressive is the magnitude of cardiovascular efficacy, including a 61 per cent reduction in the risk of stroke, that Lipitor offered these patients

Patent Victory Over Lipitor  -  Apr 2, 2007
Wall Street Journal (subscription),Pfizer Inc. preserved its US market exclusivity for the cholesterol-lowering drug Lipitor, and agreed to pay nearly $35 million to resolve government

Lipitor Significantly Lowered Hospitalization Costs for Patients ...  -  Mar 28, 2007
dBusinessNews New Orleans (press release),Pfizer announced today that Lipitor® (atorvastatin calcium) Tablets (80 mg) lowered hospitalization costs by significantly reducing the risk of

Lipitor Significantly Lowered Hospitalization Costs for Patients ...  -  Mar 27, 2007
PharmaLive.com (press release),..."One of these analyses suggests that even with the availability of low cost generics, intensive Lipitor therapy is a good economic value," said Dr. Peter

Supreme Court Rejects Lipitor Competitor Patent Appeal  -  Apr 2, 2007
Hartford Courant,WASHINGTON -- The Supreme Court on Monday rejected an appeal by a drug maker over a judge's ruling that information Pfizer withheld during a Lipitor patent

Pfizer's profit drops on charges  -  Apr 20, 2007
MarketWatchSales of the company's best-selling product, the cholesterol-lowering agent Lipitor, came in at $3.4 billion, up 8% from last year. The company's No.

Analysis: Pfizer solid despite earns dip  -  Apr 20, 2007
United Press InternationalHe noted sales of several of Pfizer's key products beat his estimates, including Lipitor, Norvasc, Celebrex, Chantix and Lyrica. In addition, the company

Pfizer wins Lipitor patent extension  -  Apr 2, 2007
Myiris.com,Pfizer, won a US Supreme Court appeal that, aimed to open the company`s Lipitor cholesterol pill, the most widely prescribed drug in the world,

Generics fears force Pfizer to cut outlook  -  Apr 20, 2007
MSNBCBut investors' greater concern continues to be about the cholesterol market, where Pfizer is trying to fight off erosion of sales to generics from Lipitor,

Supreme Court rejects appeal by Lipitor competitor over patent ruling  -  Apr 2, 2007
Therapeutics Daily (subscription) (press release),WASHINGTON_The Supreme Court on Monday rejected an appeal by a drug maker over a judge's ruling that information Pfizer withheld during a Lipitor patent

Supreme Court rejects Lipitor competitor patent appeal  -  Apr 2, 2007
WTNH,...(Washington-AP) _ The Supreme Court today rejected an appeal by a competitor of Pfizer over patents for the Lipitor cholesterol-lowering drug.

Supreme Court rejects appeal by Lipitor competitor over patent ruling  -  Apr 2, 2007
Daily Report,WASHINGTON (AP) — The Supreme Court on Monday rejected an appeal by a drug maker over a judge's ruling that information Pfizer withheld during a Lipitor

Supreme Court Rejects Appeal by Lipitor Competitor Over Patent Ruling  -  Apr 2, 2007
Law.com (subscription),The Supreme Court on Monday rejected an appeal by a drug maker over a judge's ruling that information Pfizer withheld during a Lipitor patent case was

Charges Drag Pfizer Q1 Profit Down 18%; Adj. Profit Up 10%; Cuts ...  -  Apr 20, 2007
Trading Markets,Sales growth was fuelled by Lipitor and Celebrex, apart from strong performance of Chantix, a smoking cessation drug. Worldwide sales of Lipitor totaled

Pfizer says new studies show Lipitor reduces heart patient ...  -  Mar 27, 2007
Forbes,LONDON (AFX) - Pfizer Inc said new results showed its cholesterol-fighting drug Lipitor reduced hospitalisation costs via 'significantly' reducing the risk

Pfizer 1Q Profit Falls 17.5 Percent  -  Apr 21, 2007
Wyoming News,Sales of the company's best selling drug, cholesterol reducer Lipitor, grew 8 percent to $3.36 billion, topping most Wall Street estimates.

Pfizer Earnings Fall on Drop in Norvasc, Zoloft Sales (Update5)  -  Apr 20, 2007
BloombergRevenue rose 6 percent to $12.5 billion on higher drug prices and an 8 percent raise in sales of its top-selling drug, the Lipitor cholesterol pill,

Pfizer files re-issue application for Lipitor  -  Mar 29, 2007
Moneycontrol.com,CNBC-TV18 has learnt that Pfizer has filed a re-issue application for Lipitor Patent 995 with the US Patent and Trademark Office.This might have an impact

Pfizer 1st-quarter profit falls 17.5 pc  -  Apr 20, 2007
Hindu,Sales of the company's best selling drug, cholesterol reducer Lipitor, grew 8 percent to $3.36 billion (euro2.47 billion), topping most Wall Street

Pfizer 1st-quarter profit falls 17.5 percent on charges; outlook ...  -  Apr 20, 2007
International Herald Tribune,Sales of the company's best selling drug, cholesterol reducer Lipitor, grew 8 percent to $3.36 billion (€2.47 billion), topping most Wall Street estimates.

Ranbaxy Labs loses high court appeal in Pfizer Lipitor case  -  Apr 2, 2007
MarketWatchBy Mark H. Anderson. , , ) Monday lost an appeal to the US Supreme Court in its bid to sell a generic alternative to Pfizer Inc.'s (PFE :

Pfizer 1Q profit falls 17.5 percent  -  Apr 20, 2007
Euro2day,Sales of the company''s best selling drug, cholesterol reducer Lipitor, grew 8 percent to $3.36 billion, topping most Wall Street estimates.

Pfizer Earnings Fall on Drop in Norvasc, Zoloft Sales (Update4)  -  Apr 20, 2007
BloombergRevenue rose 6 percent to $12.5 billion on higher drug prices and an 8 percent raise in sales of its top-selling drug, the Lipitor cholesterol pill.

Pfizer 1st-Quarter Profit Falls 18 Pct.  -  Apr 20, 2007
Forbes,Revenue rose 6 percent to $12.47 billion from $11.75 billion last year, as sales of the company's best selling drug, cholesterol reducer Lipitor,

Pfizer 1Q profit falls 18 percent  -  Apr 20, 2007
White Rock Reviewer,Sales of the company‘s best selling drug, cholesterol reducer Lipitor Lipitor, grew 8 percent to $3.36 billion, topping most Wall Street estimates.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional